243 related articles for article (PubMed ID: 24679990)
1. Serotonin transporter gene hypomethylation predicts impaired antidepressant treatment response.
Domschke K; Tidow N; Schwarte K; Deckert J; Lesch KP; Arolt V; Zwanzger P; Baune BT
Int J Neuropsychopharmacol; 2014 Aug; 17(8):1167-76. PubMed ID: 24679990
[TBL] [Abstract][Full Text] [Related]
2. Serotonin Transporter Gene Promoter Hypomethylation as a Predictor of Antidepressant Treatment Response in Major Depression: A Replication Study.
Schiele MA; Zwanzger P; Schwarte K; Arolt V; Baune BT; Domschke K
Int J Neuropsychopharmacol; 2021 Mar; 24(3):191-199. PubMed ID: 33125470
[TBL] [Abstract][Full Text] [Related]
3. Pharmacoepigenetics of depression: no major influence of MAO-A DNA methylation on treatment response.
Domschke K; Tidow N; Schwarte K; Ziegler C; Lesch KP; Deckert J; Arolt V; Zwanzger P; Baune BT
J Neural Transm (Vienna); 2015 Jan; 122(1):99-108. PubMed ID: 24809685
[TBL] [Abstract][Full Text] [Related]
4. Norepinephrine and serotonin transporter genes: impact on treatment response in depression.
Baffa A; Hohoff C; Baune BT; Müller-Tidow C; Tidow N; Freitag C; Zwanzger P; Deckert J; Arolt V; Domschke K
Neuropsychobiology; 2010; 62(2):121-31. PubMed ID: 20588071
[TBL] [Abstract][Full Text] [Related]
5. HTR1A/1B DNA methylation may predict escitalopram treatment response in depressed Chinese Han patients.
Wang P; Lv Q; Mao Y; Zhang C; Bao C; Sun H; Chen H; Yi Z; Cai W; Fang Y
J Affect Disord; 2018 Mar; 228():222-228. PubMed ID: 29275155
[TBL] [Abstract][Full Text] [Related]
6. Association of Serotonin Transporter Gene AluJb Methylation with Major Depression, Amygdala Responsiveness, 5-HTTLPR/rs25531 Polymorphism, and Stress.
Schneider I; Kugel H; Redlich R; Grotegerd D; Bürger C; Bürkner PC; Opel N; Dohm K; Zaremba D; Meinert S; Schröder N; Straßburg AM; Schwarte K; Schettler C; Ambrée O; Rust S; Domschke K; Arolt V; Heindel W; Baune BT; Zhang W; Dannlowski U; Hohoff C
Neuropsychopharmacology; 2018 May; 43(6):1308-1316. PubMed ID: 29114103
[TBL] [Abstract][Full Text] [Related]
7. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
Kim H; Lim SW; Kim S; Kim JW; Chang YH; Carroll BJ; Kim DK
JAMA; 2006 Oct; 296(13):1609-18. PubMed ID: 17018806
[TBL] [Abstract][Full Text] [Related]
8. Serotonin transporter gene (SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients.
Manoharan A; Shewade DG; Rajkumar RP; Adithan S
Eur J Clin Pharmacol; 2016 Oct; 72(10):1215-1220. PubMed ID: 27439447
[TBL] [Abstract][Full Text] [Related]
9. Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life.
Seripa D; Pilotto A; Paroni G; Fontana A; D'Onofrio G; Gravina C; Urbano M; Cascavilla L; Paris F; Panza F; Padovani A; Pilotto A
J Psychopharmacol; 2015 May; 29(5):623-33. PubMed ID: 25827644
[TBL] [Abstract][Full Text] [Related]
10. Escitalopram efficacy in depression: a cross-ethnicity examination of the serotonin transporter promoter polymorphism.
Bousman CA; Sarris J; Won ES; Chang HS; Singh A; Lee HY; Ham BJ; Tan CH; Lee MS; Ng CH
J Clin Psychopharmacol; 2014 Oct; 34(5):645-8. PubMed ID: 24943391
[TBL] [Abstract][Full Text] [Related]
11. SLC6A4 variation and citalopram response.
Mrazek DA; Rush AJ; Biernacka JM; O'Kane DJ; Cunningham JM; Wieben ED; Schaid DJ; Drews MS; Courson VL; Snyder KA; Black JL; Weinshilboum RM
Am J Med Genet B Neuropsychiatr Genet; 2009 Apr; 150B(3):341-51. PubMed ID: 18618621
[TBL] [Abstract][Full Text] [Related]
12. Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients.
Oz MD; Baskak B; Uckun Z; Artun NY; Ozdemir H; Ozel TK; Ozguven HD; Suzen HS
Pharmacogenomics J; 2020 Jun; 20(3):443-450. PubMed ID: 31792367
[TBL] [Abstract][Full Text] [Related]
13. Serotonergic Regulation and Cognition after Stroke: The Role of Antidepressant Treatment and Genetic Variation.
Damsbo AG; Kraglund KL; Buttenschøn HN; Johnsen SP; Andersen G; Mortensen JK
Cerebrovasc Dis; 2019; 47(1-2):72-79. PubMed ID: 30844812
[TBL] [Abstract][Full Text] [Related]
14. 5-HTT mRNA level as a potential biomarker of treatment response in patients with major depression in a clinical trial.
Kao WT; Chang CL; Lung FW
J Affect Disord; 2018 Oct; 238():597-608. PubMed ID: 29957477
[TBL] [Abstract][Full Text] [Related]
15. Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample.
Kraft JB; Peters EJ; Slager SL; Jenkins GD; Reinalda MS; McGrath PJ; Hamilton SP
Biol Psychiatry; 2007 Mar; 61(6):734-42. PubMed ID: 17123473
[TBL] [Abstract][Full Text] [Related]
16. Genotype-dependent associations between serotonin transporter gene (SLC6A4) DNA methylation and late-life depression.
Lam D; Ancelin ML; Ritchie K; Freak-Poli R; Saffery R; Ryan J
BMC Psychiatry; 2018 Sep; 18(1):282. PubMed ID: 30180828
[TBL] [Abstract][Full Text] [Related]
17. Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project.
Keers R; Uher R; Huezo-Diaz P; Smith R; Jaffee S; Rietschel M; Henigsberg N; Kozel D; Mors O; Maier W; Zobel A; Hauser J; Souery D; Placentino A; Larsen ER; Dmitrzak-Weglarz M; Gupta B; Hoda F; Craig I; McGuffin P; Farmer AE; Aitchison KJ
Pharmacogenomics J; 2011 Apr; 11(2):138-45. PubMed ID: 20212518
[TBL] [Abstract][Full Text] [Related]
18. Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression.
Maron E; Tammiste A; Kallassalu K; Eller T; Vasar V; Nutt DJ; Metspalu A
Eur Neuropsychopharmacol; 2009 Jun; 19(6):451-6. PubMed ID: 19272758
[TBL] [Abstract][Full Text] [Related]
19. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.
Hu XZ; Rush AJ; Charney D; Wilson AF; Sorant AJ; Papanicolaou GJ; Fava M; Trivedi MH; Wisniewski SR; Laje G; Paddock S; McMahon FJ; Manji H; Lipsky RH
Arch Gen Psychiatry; 2007 Jul; 64(7):783-92. PubMed ID: 17606812
[TBL] [Abstract][Full Text] [Related]
20. Molecular imaging of the serotonin transporter availability and occupancy by antidepressant treatment in late-life depression.
Smith GS; Kuwabara H; Gould NF; Nassery N; Savonenko A; Joo JH; Bigos KL; Kraut M; Brasic J; Holt DP; Hall AW; Mathews WB; Dannals RF; Nandi A; Workman CI
Neuropharmacology; 2021 Aug; 194():108447. PubMed ID: 33450276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
